Commonwealth Coat of Arms of Australia

 

Health Insurance (Section 3C – Diabetes Testing in Aboriginal and Torres Strait Islander Primary Health Care Sites) Determination 2025

I, Mary Warner, delegate for the Minister for Health and Ageing, make the following Determination.

Dated 28 November 2025

Mary Warner

Assistant Secretary

Diagnostic Imaging and Pathology Branch

Medicare Benefits and Digital Health Division

Health Resourcing Group

Department of Health, Disability and Ageing

 

 

 

1  Name...................................................1

2  Commencement............................................1

3  Authority................................................1

4  Schedules................................................1

5  Definitions...............................................1

6  Circumstances where this instrument applies...........................2

7  Treatment of relevant services....................................2

Schedule 1—Relevant services 3

Schedule 2—Repeals 4

Health Insurance (Diabetes Testing in Aboriginal and Torres Strait Islander Primary Health Care Sites) Determination 2015              4

 

 

  This instrument is the Health Insurance (Section 3C – Diabetes Testing in Aboriginal and Torres Strait Islander Primary Health Care Sites) Determination 2025.

  1.     Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 March 2026.

1 March 2026

Note:  This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

  1.     Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

  This instrument is made under subsection 3C(1) of the Health Insurance Act 1973.

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

 (1) In this instrument:

Act means the Health Insurance Act 1973.

QAAMS Program means the program, known as the Quality Assurance for Aboriginal and Torres Strait Islander Medical Services Program, funded by the Department of Health, Disability and Ageing as a program to provide a culturally appropriate and clinically effective diabetes diagnosis and management service for First Nations people.

relevant provisions means all provisions, of the Act and regulations made under the Act, and the National Health Act 1953 and regulations made under the National Health Act 1953, relating to medical services, professional services oritems.

relevant service means a health service, as defined in subsection 3C(8) of the Act, that is specified in the Schedule.
 

Note: Unless the contrary intention appears, expressions used in this instrument have the same meanings as in the Act—see section 13 of the Legislative Instruments Act 2003.

 (2) Unless the contrary intention appears, in this instrument a reference to a provision of the Act or regulations made under the Act as applied, adopted or incorporated in relation to specifying a matter is a reference to those provisions as in force from time to time and any other reference to provisions of an Act or regulations is a reference to those provisions as in force from time to time.

  This instrument applies to a relevant service only where all of the following circumstances apply.

 (a) the service is rendered by or on behalf of a medical practitioner; and

 (b) the practitioner referred to in paragraph (a), or the organisation for which the practitioner works, is participating in the QAAMS Program; and

 (c) the service is provided in accordance with the QAAMS Program; and

 (d) the practitioner referred to in paragraph (a) has determined the service to be necessary for their patient.

  For subsection 3C(1) of the Act, a relevant service, provided in accordance with this instrument and as a clinically relevant service, is to be treated, for the relevant provisions, as if:

 (a) it were both a professional service and a medical service; and

 (b) there were an item in the pathology services table that is related to the service.


 

Group P9— Simple Basic Pathology Tests

Column 1

Item

Column 2

Description

Column 3

Fee ($)

73839

Quantitation of HbA1c (glycated haemoglobin) performed for the diagnosis of diabetes in asymptomatic patients at high risk - not more than once in a 12 month period

16.80

73840

Quantitation of glycosylated haemoglobin performed in the management of established diabetes – each test to a maximum of 4 tests in a 12 month period

17.00

73844

Quantitation of urinary albumin/creatine ratio in urine on a random spot collection in the management of patients with established diabetes or patients at risk of microalbuminuria

20.35

 


1  The whole of the instrument

Repeal the instrument.